The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases

Jonsson Comprehensive Cancer Center

Status: Completed

Conditions: Inflammation; Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01180907

10-000269 (Other Identifier)

CIRMNo. RT1-01126-1 (Other Grant/Funding Number)

DE-PS02-08ER-08-01 (Other Grant/Funding Number)

07-07-071

Details and patient eligibility

About

The purpose of the study is to determine whether positron emission tomography using the new imaging agent 18F-FAC can be used for imaging cancer and/or inflammation.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• > 18 years of age
• women of childbearing potential will undergo a pregnancy test free of charge
• patients with cancer or autoimmune diseases or healthy subjects

Trial design

10 participants in 3 patient groups

patients with cancer

patients with autoimmune diseases

healthy subjects